Journal Article

Risk of Immunologic Reactions During Monthly Therapy for Hansen Disease

JAMA Dermatology (2026)
DOI: 10.1001/jamadermatol.2026.1262
0Citations
Citations of this article
1Readers
Mendeley users who have this article in their library.
Get full text

Abstract

This cohort study examines the type 1 and type 2 reactions associated with the monthly regimen of rifampin, moxifloxacin, and minocycline among patients with leprosy.

Cite

CITATION STYLE

APA

Warp, P. V., Kim, M., Williams, K., Miner, A., & Maderal, A. D. (2026). Risk of Immunologic Reactions During Monthly Therapy for Hansen Disease. JAMA Dermatology. https://doi.org/10.1001/jamadermatol.2026.1262

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free